Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Extrawell Pharmaceutical Holdings Limited ( (HK:0858) ) has shared an update.
Extrawell Pharmaceutical Holdings Limited has announced a special general meeting to be held on March 28, 2025, in Hong Kong. The primary agenda is to appoint SFAI (HK) CPA Limited as the company’s auditor until the next annual general meeting, with the board authorized to set the auditor’s remuneration. This decision could impact the company’s financial transparency and stakeholder confidence.
More about Extrawell Pharmaceutical Holdings Limited
Extrawell Pharmaceutical Holdings Limited operates in the pharmaceutical industry, focusing on the development, manufacture, and distribution of pharmaceutical products. The company is primarily engaged in providing healthcare solutions and is positioned in the market to address various medical needs.
YTD Price Performance: -12.00%
Average Trading Volume: 1,323,333
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$105.2M
For detailed information about 0858 stock, go to TipRanks’ Stock Analysis page.